Skip to main content
. 2000 Sep 12;97(20):10990–10995. doi: 10.1073/pnas.180329197

Table 3.

Changes in PSA levels in prostate cancer patients treated with troglitazone

Changes in PSA Overall, n = 41 Androgen-dependent, n = 12 Androgen-independent, n = 29
>50% Decrease 1/41 1/12 0/29
<50% Decrease 7/41 3/12 4/29
No decrease 33/41 8/12 25/29
Median time on study 18+ weeks 20+ weeks 18+ weeks
HHS Vulnerability Disclosure